Latest News about Briefs
Recent news which mentions Briefs
From Benzinga
Asia Mixed, Europe Markets Down, Gold Nears $2,750 - Global Markets Today While US Slept
October 21, 2024
From Benzinga
Boeing Lands Big Win: Emirates Orders 5 More 777 Freighters
October 21, 2024
From Benzinga
Oklo, CleanSpark And Wolfspeed Are Among Top 7 Mid Cap Gainers Last Week (Oct 14-18): Are The Others In Your Portfolio?
October 20, 2024
From Benzinga
NIO, ASML, And CVS Health Are Among Top 10 Large Cap Losers Last Week (Oct 14-18): Are The Others In Your Portfolio?
October 20, 2024
From Benzinga
Coinbase, United Airlines And Sofi Tech Are Among Top 11 Large Cap Gainers Last Week (Oct 14-18): Are The Others In Your Portfolio?
October 20, 2024
From Benzinga
Consumer Tech News (Oct 14-18): Biden Administration Considers Imposing Restrictions On Chip Sales, Apple Inks Secret Deal With BYD & More
October 20, 2024
From Benzinga
What's Going On With Nokia Stock On Friday?
October 18, 2024
From Benzinga
After US Senator, Unions Urge Federal Trade Commission To Block Novo's $16.5B Acquisition Of Catalent
October 18, 2024
From Benzinga
PureCycle Gains From First-Mover Advantage And Unique Recycling Technology, Analyst Highlights Expansionary Moves
October 18, 2024
From Benzinga
BofA Upgrades Tyra Biosciences As Investors Focus On Preclinical Data Amid High Benchmarks Set By Johnson & Johnson's Drug
October 18, 2024
From Benzinga
After Failed Confirmatory Trial, Gilead Withdraws US Accelerated Approval Of Trodelvy As Bladder Cancer treatment
October 18, 2024
From Benzinga
This Bullish Analyst Highlights Taiwan Semi's 3nm Strength and Margin Expansion Potential, Raises Forecast
October 18, 2024
From Benzinga
European Medicines Agency's Panel Supports Approval Of Novartis' Kisqali In Patients With Early-Breast Cancer
October 18, 2024
From Benzinga
France's PAI Partners Ups Bid for Sanofi's Consumer Health Division As French Government Hints Possible Regulatory Block
October 18, 2024
From Benzinga
Europe Drug Regulator's Advising Panel Recommends Approval Of Novo Nordisk's Australia-Approved Hemophilia Drug
October 18, 2024
From Benzinga
Old Dominion Freight Line Faces Sluggish Industrial Demand, Analyst Downgrades Stock
October 18, 2024
From Benzinga
American Express' Mixed Q3 Results: Goldman Analyst Sees Silver Lining In Expense Management And NII Growth
October 18, 2024
From Benzinga
OpenAI's For Profit Structure Adds Valuation Complexity to Microsoft And Other Equity Investors: Report
October 18, 2024
From Benzinga
Why Is Renewable Energy Company Ameresco Stock Gaining Today?
October 18, 2024
From Benzinga
Spirit AeroSystems Plans Employee Furloughs Amid Ongoing Boeing Strike, Faces Layoff Risk
October 18, 2024
From Benzinga
What's Going On With Nvidia Stock On Friday?
October 18, 2024
From Benzinga
What's Going On With TreeHouse Foods Stock Today?
October 18, 2024
From Benzinga
US Hospitals Face Critical IV Fluid Shortage After Baxter Facility Shuts Down Due To Hurricane Helene
October 18, 2024
From Benzinga
What's Going On With Trump Media & Technology Group Stock On Friday?
October 18, 2024
From Benzinga
Merck Virus Treatment Shows 60.4% Effectiveness, Reduces Certain Infections In Infants
October 18, 2024
From Benzinga
US Cellular Sells Key Spectrum Licenses To Verizon In $1B Deal
October 18, 2024
From Benzinga
Alibaba Eyes Double-Digit Growth for Singles' Day in Hong Kong, Waives Delivery Fees
October 18, 2024
From Benzinga
From Benzinga
Why Is NIO Stock Gaining Today?
October 18, 2024
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
